U.S. Markets open in 61 hrs, 49 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 45.90 03:59 PM EDT | |
|---|---|---|
| Day High | 46.70 09:30 AM EDT |
|
| Range | 0.80 |
| Volume | 6.90 M | |
|---|---|---|
| 30-Day Avg Vol | 7.82 M |
|
| Difference | -11.86% |
| Market Cap | 41.60 B | |
|---|---|---|
| Mkt Cap Chg | -842.94 M |
| Shares Out | 906.39 M | |
|---|---|---|
| % Shrs Traded | 0.76% | |
| 1yr EPS Est | 2.523 |
| 52-Wk Low | 35.60 10/10/08 | |
|---|---|---|
| 52-Wk High | 57.63 8/13/08 |
|
| Range | 22.03 |
| Prev Close | 46.83 7/1/09 | |
|---|---|---|
| Today's Open | 46.51 | |
| Change | -0.68% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 17.38 M |
| Revenue (LFY) | 5.33 B | |
|---|---|---|
| Earnings (LFY) | 2.01 B | |
| Earnings (MRQ) | 589.11 M | |
| Next Earn Est | 0.61 | |
| Next Earnings | 07/21/2009 |
|
| EPS (TTM) | 2.21 | |
| 1yr EPS Growth | 14.16% |
| P/E Ratio (TTM) | 20.68 | |
|---|---|---|
| P/E Ratio (Fwd) | 18.00 | |
| PEG Ratio | 1.05 | |
| Return on Equity | 51.91 | |
| Beta | 0.48 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Gilead Sciences has biotech balms for infectious diseases, including hepatitis, HIV, and infections related to AIDS. The company's HIV franchise includes blockbuster Truvada, a combination of two of its ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.61 7/21/09 | — — |
—
—
|
| Last Quarter | 0.594 3/31/09 | 0.63 3/31/09 |
0.036
Beat
|
| 2 Quarters Ago | 0.545 12/31/08 | 0.60 12/31/08 |
0.055
Beat
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 1.53 B | 5.34 B |
| Gross Profit | 1.20 B | 4.21 B |
| Operating Income | 808.32 M | 2.69 B |
| Net Income | 589.11 M | 2.01 B |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts